SCHEMBL19682223

SCHEMBL19682223

C[C@@H]1OC(CO)[C@@H](O)C(O[C@@H]2OC(CO)[C@@H](O)C(O)C2O)C1O

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ AMY1A P0DUB6 1/20 0.51
▸ LGALS8 O00214 1/20 0.48
▸ LGALS3 P17931 1/20 0.48
▸ LGALS4 P56470 1/20 0.48
▸ GJA1 P17302 1/20 0.47
▸ GJB2 P29033 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ SELE P16581 1/20 0.46
▸ CD209 Q9NNX6 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ PTPN1 P18031 1/20 0.44
▸ AMY2A P04746 1/20 0.44
▸ IGF2R P11717 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23126082 1.00 MEN1 (0.52) MEN1KMT2AAMY1ALGALS8LGALS3
SCHEMBL16587626 1.00 MEN1 (0.52) MEN1KMT2AAMY1ALGALS8LGALS3
SCHEMBL13078069 1.00 MEN1 (0.52) MEN1KMT2AAMY1ALGALS8LGALS3
SCHEMBL12127166 1.00 MEN1 (0.52) MEN1KMT2AAMY1ALGALS8LGALS3
SCHEMBL23844351 1.00 MEN1 (0.52) MEN1KMT2AAMY1ALGALS8LGALS3
SCHEMBL12129496 1.00 MEN1 (0.52) MEN1KMT2AAMY1ALGALS8LGALS3
SCHEMBL23844387 1.00 MEN1 (0.52) MEN1KMT2AAMY1ALGALS8LGALS3
SCHEMBL15130864 0.98 MEN1 (0.51) MEN1KMT2AAMY1ALGALS8LGALS3
SCHEMBL15132503 0.98 MEN1 (0.51) MEN1KMT2AAMY1ALGALS8LGALS3
SCHEMBL19682224 0.98 MEN1 (0.51) MEN1KMT2AAMY1ALGALS8LGALS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190247495-A1 NOVEL SYNTHETIC ANTICANCER, ANTIFUNGAL, AND ANTIBACTERIAL VACCINES WAYNE STATE UNIVERSITY 2019-08-15 — — US disclosed
US-20170348414-A1 NOVEL SYNTHETIC ANTICANCER, ANTIFUNGAL, AND ANTIBACTERIAL VACCINES WAYNE STATE UNIVERSITY (US) 2017-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190247495-A1 NOVEL SYNTHETIC ANTICANCER, ANTIFUNGAL, AND ANTIBACTERIAL VACCINES ERG28, DDOST, STT3A MEN1 692/4885KMT2A 2957/4885AMY1A 2702/4885
US-20170348414-A1 NOVEL SYNTHETIC ANTICANCER, ANTIFUNGAL, AND ANTIBACTERIAL VACCINES ERG28, DDOST, STT3A MEN1 692/4885KMT2A 2957/4885AMY1A 2702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback